Clinical Trial Update: A Study of the Safety and Effectiveness of Topiramate on Insulin Sensitivity in Overweight or Obese Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated the safety and potential improvement in insulin sensitivity with Topiramate in overweight or obese adults with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Topamax (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Obesity, Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED